Utilizing brain imaging for analgesic drug development

Current Opinion in Investigational Drugs

Volumn 3, Issue 9, 2002, Pages 1342-1347

  Borsook, David ^a   Ploghaus, Alexander ^a   Becerra, Lino ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Analgesics; Central nervous system; Functional neuroimaging; Pain

Indexed keywords

ANALGESIC AGENT; GABAPENTIN; LAMOTRIGINE; MORPHINE; PLACEBO;

ANALGESIA; ANALGESIC ACTIVITY; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL TRIAL; CONSCIOUSNESS; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; DRUG USE; GENOTYPE; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMAGE ANALYSIS; METHODOLOGY; MORPHINE ADDICTION; NAUSEA; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PREDICTION; REVIEW; SIDE EFFECT; SOMNOLENCE;

ANALGESICS; ANIMALS; BRAIN; CLINICAL TRIALS; HUMANS; MAGNETIC RESONANCE IMAGING; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036771444     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, Vinik A, Giuliani M, Stevens JC, Barbano R, Dyck PJ: Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group. J Am Med Assoc (2000) 284:2215-2221. A good example of problems associated with drug development, includes data from a positive phase II trial and a failed phase III trial.
2. Gilron I, Booher SL, Rowan JS, Max MB: Topiramate in trigeminal neuralgia: A randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol (2001) 24:109-112.
3. Rabben T, Skjelbred P, Oye I: Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain. J Pharmacol Exp Ther (1999) 289:1060-1066.
4. Gybels JM, Sweet WH: Neurosurgical treatment of persistent pain. Physiological and pathological mechanisms of human pain. Pain Headache (1989) 11:1-402.
5. Apkarian AV: Functional magnetic resonance imaging of pain consciousness: Cortical networks of pain critically depend on what is implied by "pain". Curr Rev Pain (1999) 3:308-315.
6. Casey KL: Concepts of pain mechanisms: The contribution of functional imaging of the human brain. Prog Brain Res (2000) 129:277-287.
7. Peyron R, Laurent B, Garcia-Larrea L: Functional imaging of brain responses to pain. A review and meta-analysis Neurophysiol Clin (2000) 30:263-288.
8. Aziz Q, Schnitzler A, Enck P: Functional neuroimaging of visceral sensation. J Clin Neurophysiol (2000) 17:604-612.
9. Davis KD: The neural circuitry of pain as explored with functional MRI. Neurol Res (2000) 22:313-317.
10. Prince DD: Psychological and neural mechanisms of the affective dimension of pain. Science (2000) 288:1769-1772.
11. Price DD: Psychological Mechanisms of Pain and Analgesia. IASP Press, Seattle, WA, USA (1999).
12. Becerra L, Breiter HC, Wise R, Gonzalez RG, Borsook D: Reward circuitry activation by noxious thermal stimuli. Neuron (2001) 32:927-946. Defines novel circuitry in pain pathways including segregation of centers involved in primary sensory information and motivational centers.
13. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS: Regional μ opioid receptor regulation of sensory and affective dimensions of pain. Science (2001) 293:311-315. Rapid focal changes in μ-opioid binding following painful stimuli. This will add an important dimension in evaluating the site of analgesic actions but not necessarily behavior.
14. Davis KD, Kwan CL, Crawley AP, Mikulis DJ: Functional MRI study of thalamic and cortical activations evoked by cutaneous heat, cold, and tactile stimuli. J Neurophysiol (1998) 80:1533-1546. Unravelling sensory processing of pain in CNS pathways.
15. Casey KL, Svensson P, Morrow TJ, Raz J, Jone C, Minoshima S: Selective opiate modulation of nociceptive processing in the human brain. J Neurophysiol (2000) 84:525-533.
16. Bushnell MC, Duncan GH, Hofbauer RK, Ha B, Chen JL, Carrier B: Pain perception: Is there a role for primary somatosensory cortex? Proc Natl Acad Sci USA (1999) 96:7705-7709.
17. Da Silva A, Becerra L, Geatrakas C, Strassman A, Makris N, Keith D, Gonzalez G, Breiter H, Borsook D: fMRI activation in the trigeminal pain pathway (SPV, thalamus, SI) following noxious heat. Abstr Soc Neurosci (2001) 27:Abs 507.1.
18. Coghill RC, Morrow TJ: Functional imaging of animal models of pain: High-resolution insights into nociceptive processing. In: Pain Imaging, Progress in Pain Research and Management Vol 18. Casey KL, Bushnell MC (Eds), IASP Press, Seattle, WA, USA (2000):Chapter 8.
19. Budinger TF, Benaron DA, Koretsky AP: Imaging transgenic animals. Ann Biomed Eng (1999) 1:611-648.
20. Porszasz R, Beckmann N, Bruttel K, Urban L, Rudin M: Signal changes in the spinal cord of the rat after injection of formalin into the hindpaw: Characterization using functional magnetic resonance imaging. Proc Natl Acad Sci USA (1997) 94:5034-5039. Imaging of spinal cord in the rat following pain stimuli.
21. Henderson LA, Yu PL, Frysinger RC, Galons JP, Bandler R, Harper RM: Neural responses to intravenous serotonin revealed by functional magnetic resonance imaging. J Appl Physiol (2002) 92:331-342.
22. Mogil JS: The genetic medication of individual differences in sensitivity to pain and its inhibition. Proc Natl Acad Sci USA (1999) 96:7744-7751.
23. Iadarola MJ, Max MB, Berman KF, Byas-Smith MG, Coghill RC, Gracely RH, Bennett GJ: Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain (1995) 63:55-64. This paper defines important differences in thalamic activation in patients with neuropathic pain. Such changes will add to pathognomic CNS patterns defining the condition.
24. Woolf CJ, Salter MW: Neuronal plasticity: Increasing the gain in pain. Science (2000) 288:1765-1769.
25. Borsook D, Becerra L, Breiter H, Gonzalez G (Eds): fMRI of Hyperalgesia Following Noxious Heat. IASP Press, Vienna, Austria (2000).
26. Breiter HC, Becerra L, Gonzalez RG, Jenkins L, Huffman E, Harter K, Comite A, Borsook D: Morphine induced reward and pain circuitry activation in drug naive humans. 19th Annual Scientific Meeting of the American Pain Society, Atlanta, GA, USA (2000):Abs 703.
27. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. J Am Med Assoc (1998) 280:1837-1842.
28. Eisenberg E, Lurie Y, Braker C, Daoud D, Ishay A: Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology (2001) 57:505-509.
29. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL: Defining the clinically important difference in pain outcome measures. Pain (2000) 88:287-294.
30. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A: Neurophysiological investigation of the basis of the fMRI signal. Nature (2001) 412:150-157. Ground-breaking paper on physiological basis of the BOLD signal.
31. Rees G, Friston K, Koch C: A direct quantitative relationship between the functional properties of human and macaque V5. Nat Neurosci (2000) 3:716-723.
32. Heeger DJ, Huk AC, Geisler WS, Albrecht DG: Spikes versus BOLD: What does neuroimaging tell us about neuronal activity? Nat Neurosci (2000) 3:631-633.
33. Arthurs OJ, Boniface S: How well do we understand the neural origins of the fMRI BOLD signal? Trends Neurosci (2002) 25:27-31.
34. Ogawa S, Lee TM, Stepnoski R, Chen W, Zhu XH, Ugurbil K: An approach to probe some neural systems interaction by functional MRI at neural time scale down to milliseconds. Proc Natl Acad Sci USA (2000) 97:11026-11031.
35. Lahti KM, Ferris CF, Li F, Sotak CH, King JA: Imaging brain activity in conscious animals using functional MRI. J Neurosci Methods (1998) 82:75-83.